News | Interventional Radiology | May 15, 2018

U.S. First Lady Melania Trump Undergoes Interventional Radiology Embolization Procedure

U.S. First Lady Melania Trump Undergoes Interventional Radiology Embolization Procedure

May 15, 2018 — U.S. First Lady Melania Trump underwent an interventional radiology embolization procedure to treat a benign kidney condition, according to a statement from the White House Press Office.

The White House said the procedure was successful and there were no complications. Mrs. Trump is at Walter Reed National Military Medical Center in Bethesda, Md., and she will likely remain in the hospital for the duration of the week.  

Catheter-based embolization can be used to stop bleeding, as in cases of trauma, or to starve a fibroid or tumor of its blood supply, as may be the case in the treatment performed on Mrs. Trump, said Society of Interventional Radiology (SIR) President M. Victoria Marx, M.D., FSIR, an interventional radiologist at Keck School of Medicine Medicine at the University of Southern California (USC). 

"In performing an embolization, the IR will make a small incision in the skin and insert a thin catheter into the artery. Using real-time image guidance, the interventional radiologist then guides the catheter to the point of treatment—in Mrs. Trump’s case, the kidney — and releases an agent to stop the flow of blood. This agent could be a coil, beads, gel or foam," Marx explained. "The beauty of this solution is that no open surgery is required, reducing both the patient’s risk and recovery time. In many cases, patients can go home the same day. Sometimes a short stay in the hospital is required, depending upon the patient and area treated."

In addition to renal masses, embolization can be used to treat a wide variety of diseases and conditions, including:

  • Hemorrhage due to trauma;
  • Uterine fibroids and postpartum hemorrhage through uterine artery embolization (UAE);
  • Cancer through chemoembolization (TACE) or radioembolization (Y-90);
  • Enlarged prostate through prostatic artery embolization (PAE), and other indications. 

The White House statement said the First Lady looks forward to a full recovery so she can continue her work with children. On May 7, Mrs. Trump launched her BE BEST campaign, an awareness effort focused around the well-being of children. The campaign focuses on the social and emotional health of children, social media, and understanding both the positive and negative effects it has on children, and opioid abuse and how to protect children from its effects.

Read the related article "Capitol Hill Briefing Explores Role of Interventional Radiology in Healthcare."

 

 

Related Content

Among high-risk, chronic, coronary patients who undergo angioplasty, there were no additional benefits from ticagrelor compared to the current standard of care clopidogrel. #AHA #AHA20 #AHA2020
News | Cath Lab | November 16, 2020
November 16, 2020 — The use of the more potent antiplatelet medication ticagrelor (Brilinta) was not superior to clop
A large subgroup analysis of the VOYAGER PAD randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. #TCT2020 #TCTconnect
Feature | Cath Lab | October 18, 2020
October 18, 2020 – A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benef
A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin capped fibrous atheroma (TCFA). #TCTconnect #TCT2020

A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin cap fibro-atheroma (TCFA).

News | Cath Lab | October 18, 2020
October 18, 2020 – Data from the...
The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions. #TCT2-0

The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions.

Feature | Cath Lab | October 16, 2020
October 15, 2020 — Shockwave Medical's Intravascular Lithotripsy (IVL) system to treat severely calcified coronary ar
Videos | Cath Lab | October 16, 2020
This is an example pf the Shockwave Medical Intravascular Lithotripsy (IVL) catheter system designed to break up heav
Videos | Cath Lab | July 15, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, offers an over
Videos | Cath Lab | July 13, 2020
The Vieussens’ arterial ring (VAR) is a connection between the conus artery and the left anterior descending (LAD) co
News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major